Naval Daver, MD, Tapan Kadia, MD - Opportunity Knocks in AML: Guidance on Achieving Truly Personalized Care in Challenging Populations with Modern Therapeutics

This content has been developed for healthcare professionals only.
Patients who seek health information should consult with their
physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides,
and complete CME/MOC/NCPD/CPE information, and to apply for
credit, please visit us at PeerView.com/HGC865. CME/MOC/NCPD/CPE
credit will be available until October 5, 2025.


Opportunity Knocks in AML: Guidance on Achieving Truly
Personalized Care in Challenging Populations with Modern
Therapeutics


In support of improving patient care, Medical Learning Institute,
Inc. is jointly accredited by the Accreditation Council for
Continuing Medical Education (ACCME), the Accreditation Council
for Pharmacy Education (ACPE), and the American Nurses
Credentialing Center (ANCC), to provide continuing education for
the healthcare team.


This activity is developed in collaboration with our educational
partner, PVI, PeerView Institute for Medical Education.


SupportThis activity is supported by
independent educational grants from AbbVie, Actinium
Pharmaceuticals, Astellas, Daiichi Sankyo, Inc., Janssen Biotech,
Inc., administered by Janssen Scientific Affairs, LLC (which are
both Johnson & Johnson companies), Kura Oncology, Inc., and
Syndax.


Disclosure information is available at the beginning of the video
presentation.